Is cefotaxime (Cefotaxime) available in an oral formulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 26, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Cefotaxime is not available in oral form, and it is only administered as an injectable medication, typically given intravenously (IV) or intramuscularly (IM). Cefotaxime is a third-generation cephalosporin antibiotic used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and certain types of meningitis. The lack of oral formulation is due to poor oral bioavailability, meaning the drug would not be adequately absorbed from the gastrointestinal tract to reach effective concentrations in the bloodstream. For patients requiring cephalosporin treatment who can take oral medications, physicians typically prescribe alternative oral cephalosporins such as cefuroxime, cefpodoxime, or cefdinir. If a patient has been receiving cefotaxime injections in a hospital setting and is ready to transition to oral therapy, the healthcare provider will select an appropriate oral antibiotic based on the specific infection being treated and the sensitivity of the causative organism.

Some key points to consider when treating patients with cefotaxime include:

  • The recommended dosage and administration route, as outlined in studies such as 1 and 2
  • The potential for resistance and the need to consider local resistance profiles, as discussed in 3
  • The importance of selecting an appropriate oral antibiotic when transitioning from injectable cefotaxime, as noted in 4
  • The need to consider the specific infection being treated and the sensitivity of the causative organism, as emphasized in 5, 1, and 6

Overall, while cefotaxime is an effective antibiotic for treating various bacterial infections, its lack of oral formulation and potential for resistance require careful consideration and selection of alternative oral antibiotics when necessary.

From the Research

Cefotaxime Administration

  • Cefotaxime is administered intramuscularly or intravenously, as stated in the study 7.
  • There is no mention of an oral form of cefotaxime in the provided studies 7, 8, 9.

Oral Cephalosporins

  • The study 10 discusses new oral cephalosporins, including cefixime, cefprozil, cefpodoxime proxetil, and loracarbef, but does not mention cefotaxime as an oral cephalosporin.
  • Another study 11 compares the antibacterial activity and beta-lactamase stability of eleven oral cephalosporins, but cefotaxime is not included in the list.

Conclusion on Cefotaxime

  • Based on the provided studies, cefotaxime is not available in an oral form, but rather is administered intramuscularly or intravenously 7, 8, 9.

References

Guideline

sexually transmitted diseases treatment guidelines, 2006.

MMWR Recommendations and Reports, 2006

Related Questions

Can cefoxitin be administered intramuscularly (IM)?
What is the recommended dosage of cefotaxime (Cefotaxime) administered intravenously (IV)?
What solvent should be used to reconstitute cefotaxime?
What are the differences between cefuroxime and cefixime?
Does cefotaxime (Cefotaxime) require dose reduction in patients with Chronic Kidney Disease (CKD) stage 4 and impaired renal function?
What does a positive Antinuclear Antibody (ANA) screen with reflex to Antinuclear Antibody (ANA) panel indicate?
Does Zosyn (piperacillin/tazobactam) cover Lyme disease (Borrelia burgdorferi infection)?
Should budesonide (corticosteroid) be withheld in a patient with an active infection?
What adjustments should be made to the current levothyroxine (T4) medication regimen, with the patient taking 60 mg of Armor (levothyroxine) in the morning and 15 mg in the evening, given the following laboratory results: elevated Thyroid-Stimulating Hormone (TSH), normal Total T4, decreased Triiodothyronine (T3) uptake, elevated Total T3, normal Free T3, and elevated Reverse T3, and normal Free T4?
Is saxagliptin (Saxagliptin) suitable for patients with Chronic Kidney Disease (CKD) stage 4, characterized by Impaired Renal Function?
What adjustments should be made to the current levothyroxine (T4) medication regimen, with the patient taking 60 mg of Armor (levothyroxine) in the morning and 15 mg in the evening, given the lab results showing elevated Total T3 and Free T3, elevated Reverse T3, and normal Thyroid-Stimulating Hormone (TSH) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.